Raphael Pharmaceutical (RAPH) Cash & Current Investments (2020 - 2025)
Raphael Pharmaceutical's (RAPH) quarterly Cash & Current Investments came in at $45000.0 in Q4 2025, up 136.84% year-on-year from $19000.0 in Q4 2024, and up 1400.0% quarter-over-quarter from $3000.0 in Q3 2025.
Raphael Pharmaceutical (RAPH) Cash & Current Investments (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has disclosed Cash & Current Investments across 6 years of filings, most recently posting $45000.0 for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $45000.0, up 136.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $45000.0 (up 136.84% YoY), and the FY2025 annual result was $45000.0, up 136.84% from the prior year.
- Cash & Current Investments came in at $45000.0 for Q4 2025 at Raphael Pharmaceutical, up from $3000.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $299000.0 in Q3 2023 to a low of $3000.0 in Q3 2025.
- The 5-year median for Cash & Current Investments is $87000.0 (2022), against an average of $113833.3.
- Across the five-year window, Cash & Current Investments jumped 655.26% in 2024 and slumped 92.5% in 2025, its largest moves.
- Raphael Pharmaceutical's Cash & Current Investments stood at $153000.0 in 2021, then surged by 88.24% to $288000.0 in 2022, then retreated by 20.14% to $230000.0 in 2023, then slumped by 91.74% to $19000.0 in 2024, then soared by 136.84% to $45000.0 in 2025.
- The last three Cash & Current Investments figures came in at $45000.0 (Q4 2025), $3000.0 (Q3 2025), and $20000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Raphael Pharmaceutical | - | - | - | 45,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 45,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 20,000.00 |
| Mar 31, 2025 | 50,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 40,000.00 |
| Jun 30, 2024 | 120,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 230,000.00 |
| Sep 30, 2023 | 299,000.00 |
| Jun 30, 2023 | 111,000.00 |
| Mar 31, 2023 | 38,000.00 |
| Dec 31, 2022 | 288,000.00 |
| Sep 30, 2022 | 93,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 81,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 37,000.00 |
| Dec 31, 2020 | 95,000.00 |
| Sep 30, 2020 | 36,000.00 |